InMode Ltd (INMD) News

InMode to Present at Upcoming Investor Conferences

InMode to Present at Upcoming Investor Conferences PR Newswire YOKNEAM, Israel, Nov. 6, 2024 YOKNEAM, Israel...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists of $98.3 million of net sales in Q3 and $31.9 million of pre-orders from the first half of 2024)

InMode Reports Third Quarter 2024 Financial Results; Quarterly GAAP Revenue of $130.2 Million (which consists...

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8 Radiofrequency Devices and Cartridge Accessories

InMode Granted Preliminary Injunction Against Online Sellers Prohibiting Counterfeit Sales of Morpheus8...

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024

InMode to Report Third Quarter 2024 Financial Results and Hold Conference Call on October 30, 2024 PR...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part of a Global Reorganization Strategy

InMode Announces Departures of President of North America, Chief Medical Officer and VP of Sales USA as Part...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares

InMode Announces Share Repurchase Program of Up to 7.68 Million Shares PR Newswire YOKNEAM, Israel, Sept. 10...

InMode to Present at 2024 Baird Global Healthcare Conference

InMode to Present at 2024 Baird Global Healthcare Conference PR Newswire YOKNEAM, Israel, Sept. 4, 2024...

InMode to Present at Upcoming Investor Conferences

InMode to Present at Upcoming Investor Conferences PR Newswire YOKNEAM, Israel, Aug. 6, 2024 YOKNEAM, Israel...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet delivered) of $102.6M

InMode Reports Second Quarter 2024 Financial Results; Quarterly Revenue of $86.4M Represents 36.5...

InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform

InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform PR...

DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer

DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire MIAMI, July 25, 2024...